Collegium [COLL] vs Perrigo Company plc [PRGO] Detailed Stock Comparison

Collegium Pharmaceutical Inc.

NASDAQ
Loading...

Perrigo Company plc

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Collegium Pharmaceutical Inc. wins in 12 metrics, Perrigo Company plc wins in 8 metrics, with 0 ties. Collegium Pharmaceutical Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Collegium Pharmaceutical Inc. Perrigo Company plc Better
P/E Ratio (TTM) 18.79 2,818.00 Collegium Pharmaceutical Inc.
Price-to-Book Ratio 3.42 0.55 Perrigo Company plc
Debt-to-Equity Ratio 310.41 131.16 Perrigo Company plc
PEG Ratio 0.49 0.91 Collegium Pharmaceutical Inc.
EV/EBITDA 3.77 7.26 Collegium Pharmaceutical Inc.
Profit Margin (TTM) 8.05% -33.51% Collegium Pharmaceutical Inc.
Operating Margin (TTM) 30.04% 10.20% Collegium Pharmaceutical Inc.
EBITDA Margin (TTM) 30.04% 10.20% Collegium Pharmaceutical Inc.
Return on Equity 23.70% -38.66% Collegium Pharmaceutical Inc.
Return on Assets (TTM) 7.27% 2.35% Collegium Pharmaceutical Inc.
Free Cash Flow (TTM) $327.58M $145.10M Collegium Pharmaceutical Inc.
Dividend Yield N/A 9.92% N/A
1-Year Return 15.34% -58.72% Collegium Pharmaceutical Inc.
Price-to-Sales Ratio (TTM) 1.35 0.38 Perrigo Company plc
Enterprise Value $1.58B $4.93B Perrigo Company plc
EV/Revenue Ratio 2.03 1.16 Perrigo Company plc
Gross Profit Margin (TTM) 62.49% 32.64% Collegium Pharmaceutical Inc.
Revenue per Share (TTM) $25 $31 Perrigo Company plc
Earnings per Share (Diluted) $1.73 $-10.12 Collegium Pharmaceutical Inc.
Beta (Stock Volatility) 0.77 0.49 Perrigo Company plc
Short % of Float 22.26% 18.67% Perrigo Company plc

Collegium Pharmaceutical Inc. vs Perrigo Company plc Stock Performance Analysis

Loading Price Chart...

COLL
PRGO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Collegium Pharmaceutical Inc.1.90%-7.78%-10.18%-22.33%-35.09%-31.78%
Perrigo Company plc0.00%-6.27%-8.17%-8.17%-25.07%-24.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Collegium Pharmaceutical Inc.15.34%55.39%54.10%108.37%159.54%159.54%
Perrigo Company plc-58.72%-66.51%-76.52%-88.64%-86.89%-34.38%

Performance & Financial Health Analysis: Collegium Pharmaceutical Inc. vs Perrigo Company plc

MetricCOLLPRGO
Market Information
Market Cap i$1.05B$1.61B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i492,2202,169,621
90 Day Avg. Volume i584,0773,503,450
Last Close$31.06$10.46
52 Week Range$28.90 - $50.79$9.23 - $28.44
% from 52W High-38.84%-63.22%
All-Time High$50.79 (Dec 29, 2025)$215.73 (Apr 06, 2015)
% from All-Time High-38.85%-95.15%
Growth Metrics
Quarterly Revenue Growth0.13%-0.03%
Quarterly Earnings Growth0.35%-0.03%
Financial Health
Profit Margin (TTM) i0.08%-0.34%
Operating Margin (TTM) i0.30%0.10%
Return on Equity (TTM) i0.24%-0.39%
Debt to Equity (MRQ) i310.41131.16
Cash & Liquidity
Book Value per Share (MRQ)$9.51$21.33
Cash per Share (MRQ)$12.18$3.86
Operating Cash Flow (TTM) i$329.32M$238.50M
Levered Free Cash Flow (TTM) i$321.54M$28.33M
Dividends
Last 12-Month Dividend Yield iN/A9.92%
Last 12-Month Dividend iN/A$1.16

Valuation & Enterprise Metrics Analysis: Collegium Pharmaceutical Inc. vs Perrigo Company plc

MetricCOLL (Apr 26, 2026)PRGO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i18.792,818.00
Forward P/E i4.824.93
PEG Ratio i0.490.91
Price to Sales (TTM) i1.350.38
Price to Book (MRQ) i3.420.55
Market Capitalization
Market Capitalization i$1.05B$1.61B
Enterprise Value i$1.58B$4.93B
Enterprise Value Metrics
Enterprise to Revenue i2.031.16
Enterprise to EBITDA i3.777.26
Risk & Other Metrics
Beta i0.770.49
Book Value per Share (MRQ) i$9.51$21.33

Financial Statements Comparison: Collegium Pharmaceutical Inc. vs Perrigo Company plc

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCOLL (2025)PRGO (2025)
Revenue/Sales i780.57M4.25B
Cost of Goods Sold i317.31M2.76B
COGS % of Revenue i40.7%64.9%
Gross Profit i463.26M1.49B
Gross Margin i59.3%35.1%
Research & Development iN/A95.40M
Operating Income (EBIT) i178.45M312.80M
Operating Margin i22.9%7.4%
EBITDA i415.82M637.10M
EBITDA Margin i53.3%15.0%
Pre-Tax Income i92.62M-1.30B
Pre-Tax Income % of Revenue i11.9%-30.5%
Income Tax i29.75M104.40M
Income Tax % of Revenue i3.8%2.5%
Net Income (Profit) i62.87M-1.43B
Profit Margin i8.1%-33.5%

Balance Sheet & Liquidity Metrics

MetricCOLL (2025)PRGO (2025)
Cash & Equivalents i231.25M531.60M
Total Current Assets i691.41M2.80B
Total Current Assets % of Revenue i88.6%65.8%
Total Current Liabilities i440.03M1.01B
Total Current Liabilities % of Revenue i56.4%23.8%
Long-Term Debt i784.46M3.60B
Long-Term Debt % of Revenue i100.5%84.7%
Total Shareholders Equity i301.68M2.94B
Retained Earnings i-101.13M-3.68B
Retained Earnings % of Revenue i-13.0%-86.5%
Property, Plant & Equipment i25.77M167.80M

Cash Flow Statement Comparison

MetricCOLL (2025)PRGO (2025)
Operating Cash Flow i329.01M-1.06B
Operating Cash Flow % of Revenue i42.2%-24.9%
Capital Expenditures i-1.74M-93.40M
Free Cash Flow i327.58M145.10M
FCF Margin i42.0%3.4%
Debt Repayment i-635.56M-34.80M
Common Stock Repurchase i-25.10MN/A

Short Interest & Institutional Ownership Analysis

MetricCOLLPRGO
Shares Short i6.03M16.69M
Short Ratio i9.323.99
Short % of Float i22.26%18.67%
Shares Outstanding i31.71M137.62M
Float Shares i31.30M136.81M
% Held by Insiders i0.94%0.41%
% Held by Institutions i120.97%115.48%
% Held by Public i-21.91%-15.89%

Dividend Analysis & Yield Comparison: Collegium Pharmaceutical Inc. vs Perrigo Company plc

MetricCOLLPRGO
Last 12-Month Dividend iN/A$1.16
Last 12-Month Dividend Yield iN/A9.92%
3-Year Avg Annual Dividend iN/A$1.12
3-Year Avg Dividend Yield iN/A1.09%
3-Year Total Dividends iN/A$3.36
Ex-Dividend DateN/AMar 02, 2026